Real-world visual outcomes with coMra therapy
From optic neuritis to post-stroke vision loss, these clinical cases show how coMra therapy helps preserve sight and restore function — even when conventional treatments plateau.
Each outcome reflects a patient’s journey and a clinician integrating coMra therapy into care. Browse quick overviews or dive into detailed notes with links to related science.
Case 1: Stroke with Headaches and Loss of Visual Field
(Click to Expand)
Quick Facts
- Patient: 68-year-old female
- Condition: Headaches and loss of visual field following stroke in the right side of the brain
- Context: Stroke caused a large blind spot affecting the left visual field of both eyes; nerve pathway involvement impacted both eyes seeing to the left.
- Protocol: Treatment started 5 months after stroke onset. 12 treatments done over 3 months. coMra Delta 905 used. Eye Protocol (point 2 only, modified, 5 minutes per side) + 50 Hz (5 minutes at stroke site). 6 syntonics treatments also done.
- Outcome Highlights:
- Visual field completely restored (confirmed by visual field testing at the end of the treatment program)
- Headaches much less frequent and much less intense
📂 Expand Full Case Details
Case Details
Medical History:
Early glaucoma, high blood pressure, diabetes, heart disease
Medications at Start:
Pravastin, Sotalol, Fenofiery, Oneprazo, Coumadin, Metfromin, Travatan Z, Aspirin, Calcium
Practitioner Notes:
- Visual field loss fully restored, confirmed by visual field testing at the end of the treatment program
- Patient reported headaches were much less frequent and much less intense
- Overall improvement rated as Substantially Improved (65–89% better)
Patient Comment:
“She is very happy!”
Follow-up:
Awaiting patient return for post-treatment check-up report
Related science:
-
Transcranial low-intensity laser + magnetic therapy improved visual fields, VEP, and ocular blood flow in POAG patients (n=165 eyes, Egorov 2013; n≈400 eyes across cohorts, Kamenskikh 2012), supporting plausibility for post-stroke field recovery.
-
In POAG with cerebral ischemia, transcranial magnetic/laser regimens improved fields, VEP latency, and hemodynamics (n≈400 eyes, Kamenskikh 2012). Similarly, in vascular and ischemic optic-nerve subgroups, multi-modal low-intensity therapy showed durable gains (n=88 eyes, Baranov 2016), suggesting mechanisms that may also underlie reduced headache burden.
Case 2: Ischemic Optic Neuropathy — Optic Neuritis (Right Eye)
(Click to Expand)
Quick Facts
- Patient: 54-year-old female
- Condition: Ischemic Optic Neuropathy – Optic neuritis in right eye (OD)
- Context: “Curtain” over vision; MRI/CAT negative; no inflammatory/traumatic cause; stress suspected. Prior steroids failed.
- Protocol: Duration from onset to start not specified. 18 treatments over ~2 months. Eye Protocol (point 2). Weekly acupuncture.
- Outcome Highlights: Acuity ~20% better (to 20/40); field defects 14 → 9 at series end; → 5 one month later.
📂 Expand Full Case Details
Case Details
Medical History: None reported
Medications at Start: Prednisone (discontinued)
Practitioner Notes:
- Continued improvement after the series ended
- Color fields expanded; fewer blind spots
- Patient noticed clearer vision near/far, better peripheral awareness
Patient Comment:
“It’s a lot less and so a lot less disturbing.”
Follow-up: Lost to follow up
Related science:
-
Coordinated low-intensity therapies — combining gentle electrical stimulation, millimeter-wave fields, and low-intensity laser, synchronized to patient rhythms — improved acuity and fields in partial optic-nerve atrophy across etiologies (n=443 eyes; vascular subgroup n=88, Baranov 2016), paralleling this case’s VA/field gains.
-
Magnet-based regimens enhanced conduction and perfusion in glaucoma (n=634 eyes, Kamenskikh 2015). In addition, transcranial magneto-laser therapy elevated neurotrophic factors and improved afferent conduction (n=217 eyes; 126 treated vs 91 controls, Egorov 2016), supporting mechanisms of optic-nerve recovery.
Case 3: Sixth Cranial Nerve Paralysis After Brain Surgery
(Click to Expand)
Quick Facts
- Patient: 49-year-old female
- Condition: Sixth cranial nerve paralysis with constant diplopia after brain surgery
- Context: Post-surgical nerve injury from right-sided brain tumor removal. Severe eye turn with constant double vision. Unable to move affected eye laterally. Visual field defect and enlarged blind spot in affected eye. Planned surgical muscle reattachment as next step in conventional care.
- Protocol: Began coMra treatment after several weeks of unsuccessful therapy with syntonics and microcurrent. 12 treatments over ~1 month. coMra Delta 905 used. Eye Protocol + 5 minutes at surgery site.
- Outcome Highlights: Full ocular alignment and motion restored. Visual acuity improved to 20/20. Visual field normalized. Diplopia resolved. Avoided surgical muscle reattachment. Returned to work in entertainment industry.
📂 Expand Full Case Details
Case Details
Practitioner Notes:
- Constant diplopia from severe lateral eye turn.
- No lateral movement in affected eye before coMra therapy.
- Prior treatments included steroids, binasal occluder, syntonic phototherapy, and frequency-specific microcurrent — all without improvement.
- After 12 coMra treatments, the eye was fully aligned, with normal range of motion.
- Visual acuity improved to 20/20 in affected eye.
- Visual field defect and enlarged blind spot normalized.
- Avoided planned surgical muscle reattachment.
- No regression at 1-year follow-up.
- Returned to work in television, having previously lost her job due to appearance-related constraints from eye misalignment.
Patient Outcome:
“Felt totally normal again; regained employment in entertainment field.” She expressed strong appreciation for the results and publicly credited the practitioner on the radio, now that she had become a radio DJ.
Follow-up:
Stable ocular alignment and function at 1-year review.
Related science:
-
Combined laser + electrical stimulation improved visual acuity and VEPs in optic-nerve atrophy (n=27 patients, Gadjieva 1994), providing an early precedent for functional recovery of the optic nerve.
-
Synchronized low-intensity modalities — laser, electrical stimulation, and millimeter-wave fields — produced sustained acuity and field improvements across optic-nerve disorders (n=443 eyes; post-traumatic subgroup n=62, Baranov 2016), consistent with functional normalization and surgical deferral.
Case 4: Proliferative Diabetic Retinopathy with Ischemic Neuropathy
(Click to Expand)
Quick Facts
- Patient: 71-year-old male
- Condition: Proliferative diabetic retinopathy with ischemic optic neuropathy in OS
- Context: Advanced diabetes, heart disease, and history of multiple retinal laser surgeries. OD completely blind (no light perception). OS with 20/80 near vision, contrast sensitivity 0.64 (normal 1.68), and severely restricted visual field.
- Protocol: 10 coMra Delta 905 Eye Protocol treatments (daily, some days twice) plus brief syntonic phototherapy.
- Outcome Highlights: No change in acuity or contrast sensitivity, but horizontal field increased from 15° to 25°, vertical from 10° to 25°, more than doubling total visual field area (~2.5×). Patient reported markedly improved ability to take in surroundings.
📂 Expand Full Case Details
Case Details
This out-of-town patient presented in poor systemic health, with vision in his only seeing eye (OS) severely impaired both in clarity and field.
Pre-treatment testing confirmed:
- Acuity: ~20/80 near vision
- Contrast sensitivity: 0.64 (normal 1.68)
- Visual field: Horizontal max 15°, vertical 10°
Treatment consisted of 10 in-office coMra sessions over two weeks, some days twice daily, using the Eye Protocol. A short course of syntonic phototherapy was also provided.
Results:
Post-treatment field measurements showed horizontal expansion to 25° and vertical to 25°,
representing more than a doubling of usable visual field area (~2.5× increase). While chart-based measures (acuity and contrast sensitivity) did not change, the patient noticed a substantial improvement in functional vision, describing it as “definitely got more space to see.”
This expansion allowed him to take in more of his environment despite unchanged sharpness, a change considered significant for daily living and mobility.
Related science:
-
Transcranial laser + magnetic therapy and trabecular-targeted laser-magnet stimulation improved fields and ocular blood flow (n=165 eyes, Egorov 2013; n=96 treated vs 94 control eyes, Sidelnikova 2014), paralleling the 2.5× field expansion here.
-
Bio-regulated ultrasound outperformed standard ultrasound on outflow and optic-nerve function (n=157 treated vs 49 control eyes, Novikova 2011), supporting functional gains even when acuity plateaus.
Case 5: Glaucoma and Optic Neuropathy in High Myopia
(Click to Expand)
Quick Facts
- Patient: 55-year-old female
- Condition: Glaucoma, optic neuropathy, high myopia
- Context: Entered treatment with restricted visual fields and left eye afferent pupil defect. Acuity stable at OD 20/25, OS 20/40.
- Protocol: 8 coMra Delta 905 treatments over 5 days (Eye Protocol), no adjunctive therapies.
- Outcome Highlights: Significant bilateral field expansion, contrast sensitivity improvement, and better nerve conduction OS. Acuity unchanged.
📂 Expand Full Case Details
Case Details
Practitioner Notes:
- Out of town patient in for short stay duration and so do multiple treatments over short period.
- Baseline: OD acuity 20/25, OS 20/40. Contrast sensitivity OD 1.56, OS 1.08. Restricted fields in both eyes. OS afferent pupil defect measured at 0.78 (anything >0.7 considered damaged).
- Treatment: 8 coMra Delta 905 sessions over 5 days (Eye Protocol).
- Results:
- Visual acuity: No change in either eye.
- Contrast sensitivity: OD improved from 1.56 to 1.68 (normal), OS from 1.08 to 1.16.
- Visual fields:
- OD horizontal: 15° → 45°, vertical: 20° → 42°
- OS horizontal: 15° → 37°, vertical: 12° → 32°
- Nerve conduction: OS afferent pupil defect improved from 0.78 to 0.67.
- Patient noticed expanded fields during treatment sessions.
Practitioner Commentary:
“This is encouraging — the afferent pupil defect improvement reflects better nerve conduction, alongside significant field expansion and contrast gains. These are functional changes that improve daily visual awareness.
Patient Outcome:
“Noticed the fields were bigger during the treatments.”
Related science:
- Transcranial laser + magnetic therapy and multi-modal stimulation (laser, electrostimulation, millimeter-wave) consistently expanded fields (n=165 eyes, Egorov 2013; n=443 eyes, Baranov 2016), matching the large field gains reported here.
- Magnet-based regimens improved electrophysiology and blood flow (n=634 eyes, Kamenskikh 2015); small-cohort low-level laser therapy showed VA and IOP benefits lasting 3 months (n=25 eyes, Kleyman 2016), aligning with contrast and afferent improvements.
Case 6: Brain Injury with Left Side Neglect & Visual Field Loss
(Click to Expand)
Quick Facts
- Patient: 61-year-old female
- Condition: Brain injury with left side neglect after cerebral hemorrhage from auto accident
- Context: Entered treatment 2 years post-injury; prior vision therapy improved acuity and coordination but no field recovery.
- Protocol: 13 coMra Delta 905 sessions, eye protocol, plus hemorrhage site.
- Outcome Highlights: Improved acuity OD, midline shift reduction, major visual field recovery, resolved headaches.
📂 Expand Full Case Details
Case Details
Practitioner Notes:
- Baseline: OD acuity 20/60-1, OS 20/20; photophobia, extreme fatigue, chronic headaches, suppression of binocular vision, midline shift syndrome, left inferior visual field loss, reduced vision OD.
- Treatment: 13 coMra Delta 905 sessions over 6 weeks. Eye Protocol, point 2 + 50Hz over site of hemorrhage (5 min).
- Results:
- Visual acuity: OD improved to 20/40-1; OS remained 20/20.
- Visual fields: OD defects reduced from 5/12 to 2/12; OS defects reduced from 4/12 to 0/12.
- Other improvements: Reduced midline shifts, improved peripheral vision and depth perception, better balance, headaches resolved.
- Practitioner assessment: ~40% overall functional improvement — a strong outcome for chronic post-injury case.
Patient Outcome:
“Blind spots greatly reduced — I can see faces now. Before, I would only see part of someone’s face because the bottom was gone. Now I can see my family’s full faces, and I feel more stable when walking.”
Related science:
-
- Field recovery mirrors gains with transcranial laser + magnetic therapy (n=165 eyes, Egorov 2013) and durable improvements from multi-modal, biocontrolled stimulation across optic-nerve etiologies including neurovascular injury (n=443 eyes total; post-traumatic n=62 eyes, Baranov 2016).
-
In cerebral ischemia, transcranial pulsed magnet ± laser therapy shortened VEP latency and improved ocular blood flow (n=91/129/97 eyes, Kamenskikh 2012), mechanisms that may also underlie relief of headaches and balance symptoms.
💡 Clinician Note — Observed Patterns Across Cases
- Functional gains are often measurable even in chronic or advanced conditions.
- Benefits can continue after treatment ends, suggesting systemic recovery processes.
- coMra therapy integrates well alongside other care, without interrupting standard management.
✅ Next Steps for Clinicians
📅 Book a Call
Explore how coMra could fit into your care model Schedule a Conversation →
📄 Read the Clinical Brief
Access protocols and objective outcomes
Get the Brief →
💬 Ask a Clinical Question
Get direct answers from our clinical team
Submit Your Question →📨